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Abstract
Purpose: The aim of this study was to investigate the prevalence of clustering by health professionals 
in individually randomised controlled trials (iRCT), and its adjustment in both the sample size 
calculation estimates and the analysis of the data collected in iRCT (that is, trials that randomise 
individuals only). As a result, cluster randomised controlled trials will not be the part of this review 
study. Additionally, the authors aimed to discover the prevalence of the various forms of clustering 
in iRCT.
Methods: iRCT, in which the intervention was delivered by a health professional, were electronically 
searched in three medical journals. The dates searched were from 1st January 2000–31st August 2009. 
The retrieved trials were then screened to exclude those with complex designs and trials with more 
than two parallel arms. The selected trials were then fully reviewed for the presence of clustering 
efects and any corresponding adjustment. Data about the sample size calculation in the selected 
trials were also included. A basic form was generated for the purpose of data extraction from each of 
the selected trials.
Results: Of the 130 iRCT reviewed, clustering of outcomes was present in 127 (98%) trials. Only 61 trials 
(47%) had adjusted for the clustering efects in their design and analysis, while 53% of the trials had 
ignored the clustering efect, and hence no adjustment had been made in the trial design or analysis.
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BACKGROUND
Researchers that individually randomised 
controlled trials (iRCT)  assume that the 
observed outcomes of participants are 
independent. In practice, there are a number of 
situations in which there is some doubt about 
the validity of this assumption. One example is 
the correlation, or clustering, of the observed 
outcomes in participants treated by the same 
health professional.1 The importance of this 
issue was emphasised by Lee and Thompson,1 
who assessed clustering in 42 iRCT and 
concluded that clustering of outcomes exists 
in almost all iRCT, but is usually ignored in the 
analysis, which leads to underestimates of 
uncertainty and overly extreme p values.1 In 
another article, Lee and Thompson proposed 
random efect models to allow for such clustering 
and investigated their efect on estimation and 
interpretation of the treatment efect.2  
INTRODUCTION 
What Does the Term Clustering Mean?
The term clustering usually diverts the mind of the 
reader towards the cluster randomised controlled 
trials, wherein the groups, or clusters, of patients 
(rather than individuals) are randomised to a 
treatment either because of the nature of the 
treatment or to prevent contamination between 
treatment groups.3 However, in this review, 
clustering in iRCT will be analysed. 
In iRCT, clustering means that the observation(s) 
about patients and observed outcomes in iRCT 
may be correlated due to diferences in the 
behaviours of the health professionals actively 
delivering the intervention, sociodemographic 
diferences between the patients, or the design 
of the study.1 Observed outcomes clustering can 
also occur by single centres when participating in 
larger multicentre randomised controlled trials.2 
Why is it Important to Consider the 
Clustering Efect?
Clustering of outcomes in randomised trials 
reduces the efective sample size, reducing the 
power of a trial to detect an intervention efect.4-6
Additionally, clustering also afects the 
generalisability of the results and conclusions.1 The 
results obtained and conclusions drawn from a 
trial cannot be generalised to the whole 
population if the potential of clustering for 
outcomes exists in a trial. For example, in therapy 
trials the sample of therapists in the trial should 
be representative of those who are going to 
deliver the intervention in practice,7 otherwise, 
the results obtained cannot be generalised.
In What Forms Does Clustering  
Exist in Individually Randomised  
Controlled Trials?
Clustering may be imposed by the design of 
the trial; this inherent clustering as a result of 
trial design has been noted in a trial comparing 
a new one-stop clinic with a dedicated breast 
clinic for breast cancer screening.8 In another 
form, clustering can be natural rather than 
imposed either because of the sociodemographic 
diferences between patients or because of the 
general practitioner’s or the practice’s inluence 
on delivering the intervention, as observed in a 
trial comparing fusidic acid cream with placebo 
for the treatment of impetigo.9
Clustering can also appear by centre in a 
multicentre trial, which was seen in a study 
comparing the cytological surveillance with 
immediate referral for colposcopy in management 
of women with low-grade cervical abnormalities.10 
Observations from the same centre were similar 
and therefore more correlated and clustered than 
those from diferent centres: this phenomenon 
deines the centre efect.11
Regarding the various forms of clustering, clustering by centre in multicentre trials was found in 79 
trials (60%), followed by natural clustering in 26 trials (20%), and clustering imposed by the design of 
the study in 23 trials (18%).
Conclusion: Potential clustering of outcomes exists in almost all iRCT; however, this review found that 
<50% of iRCT took clustering into account and adjusted the sample size calculation and statistical 
analysis of this data for clustering. Almost half of the reviewed iRCT ignored the clustering efect. As 
a result, inaccurate and nongeneralisable results could have been generated.
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How Can Clustering Efects  
Be Adjusted?
In iRCT the clustering efects can be accounted 
for by anticipating them at the time of trial design 
and increasing the sample size accordingly.12
Adjustment for the clustering efects in iRCT can 
also be conducted during the statistical analysis 
of a trial by using various statistical models.4 
When analysing data from a multicentre trial, 
the estimation of the main treatment efect must 
take into account the diferences seen between 
each centre.13-15 This statistical method to limit the 
efect of clustering is widely accepted, but there 
is no real consensus on the statistical model to 
use.16-20 However, the selected method depends 
on the application of the trial’s conclusion.11 
If conclusions apply across the participating 
centres or if the centres cannot be considered as a 
random sample from a population, the analysis of 
data will involve a ixed efects regression model. 
On the contrary, if one wants to extend the results 
to all the centres that could be concerned by 
the experimental treatment, the analysis of data 
will involve a mixed efects model.11
Time Trend of Clustering in Individually 
Randomised Controlled Trials
At present, there is no obvious trend of clustering 
prevalence and its accommodation in iRCT. One 
of the objectives of this review is to identify the 
time trend of clustering prevalence in iRCT and 
the according adjustments in such trials. The aim 
of this study is to conduct a systematic analysis of 
the iRCT for the potential efects of clustering by 
health professionals.
Objectives of this study
 > To identify the prevalence of clustering in iRCT.
 > To identify whether the researchers have 
allowed for clustering efects or ignored 
clustering efects in the selected iRCT.
 > To explore the diferent ways used to  
accommodate for clustering efects in  
the selected iRCT.
 > Analyse the time trend analysis of the 
presence of clustering in iRCT and any 
according adjustment.  
 
METHODOLOGY 
Trials to be Included in This Study
Only iRCT conducted by healthcare professionals 
have been included in this study. The term 
healthcare professional encompasses doctors, 
nurses, physiotherapists, and acupuncturists. 
iRCT involving a pharmaceutical and/or health 
technology have not been included in the inal 
selection of the studies that were reviewed. 
Likewise, cluster randomised controlled trials 
were excluded during the inal selection of 
the articles.
Study Design
This study is a systematic review of iRCT 
published in three selected journals from 1st 
January 2000–31st August 2009. The journals 
were selected for this study due to their diverse 
impact factors (at the time of the study) and 
the ease of access to the fully published articles 
from the university portal of the University of 
Sheield. The retrieved articles were fully 
reviewed for the presence of various forms of 
clustering, relevance of the assumptions made 
while calculating sample size, and adjustment 
made for the efect of clustering during 
statistical analyses. 
Strategic Plan for the Search 
Basic literature search
The electronic databases searched for relevant 
literature were Medline® via OVIDSP online, 
the university portal/OVID online, and Google 
scholar. The database was searched from 
1950 to date. The keywords used for electronic 
searching were “clustering”, “clustering efects”, 
“statistical models”, “randomised controlled 
trials”, “randomized controlled trials”, “natural 
clustering”, “multicentre trial”, “adjustment for 
clustering”, “health professional”, “individual 
randomized trials”, “individual randomized trials”, 
“sample size”, “sample size calculation”, and 
“random efect model”.
The keyword “clustering” yielded 27,084 papers, 
while the terms “randomized controlled trials” 
and “randomized controlled trials” yielded 286,121 
and 6,006 papers, respectively. The search was 
narrowed on the basis the of forms of clustering, 
models to allow for clustering, adjustment 
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methods, sample size, and sample size calculation. 
The search was further narrowed by only selecting 
iRCT and excluding cluster randomised trials. 
Finally, iRCT conducted by pharmacists and those 
with technological subjects, such as Helicobacter 
pylori, cardiac markers, and other tests were 
also excluded as these studies did not meet the 
inclusion criteria. 
Individual journal search
A separate search strategy was used for accessing 
and scrutinising each of the three journals. The 
portal and search strategy used for each of the 
journals is briely discussed below.
BMJ
The yearly archives of the online issue of BMJ 
were accessed via the HighWire Press Free line 
using the university library electronic journal 
database. Within each year, the full reports of 
the articles regarding the primary care/general 
practice were accessed, and the retrieved articles 
were categorically arranged on the basis of their 
study design. The articles in the education and 
debate portion of the archives were not accessed.
The Lancet
The electronic search was made using 
ScienceDirect via the university library electronic 
journals database. The terms “randomized 
controlled trials” and “randomised controlled 
trials” were searched via ScienceDirect. 
Articles were then selected or excluded by 
applying the limitations of the iRCT in the speciied 
time period (1st January 2000–31st August 2009), 
which reduced the number of the articles to 82. 
Records identiied 
through database 
searching
(N=381)
Records after duplicates removed
(n=381)
Abstracts screened
(n=381)
Full text articles assessed for 
eligibility
(n=221)
Studies included in qualitative 
synthesis
(n=130)
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Full text articles excluded, 
with reasons
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and/or cluster design)
Additional records 
identiied through other 
sources
(n=0)
Figure 1: The identiication, screening, and selection of the studies detailing individually randomised controlled 
trials included in this investigation. 
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Journal of Psychiatry and 
Neurosciences 
PubMed Central, accessed via the electronic 
journal database of the university library portal, 
was used to search for JPN articles. The volumes 
of the JPN were scrutinised in detail from 
January 2000–July 2009. This search yielded 30 
randomised controlled trials.
Screening of the titles and abstracts  
of the retrieved articles
The full literature search yielded 381 relevant 
articles. Two independent researchers screened 
the titles and abstracts of the retrieved articles, 
and, as a result, 160 articles were excluded. 
Full text review of the retrieved articles
A review of the full text of the selected articles 
was conducted, and, as a result, 91 articles were 
excluded on the basis of full text review because 
they did not meet the inclusion criteria. Among 
these, trials with the factorial, crossover, and/
or cluster design were excluded. Additionally, 
the follow-up studies were excluded from the 
retrieved articles (Figure 1). 
Data Extraction 
The iRCT selected for the inal analysis were 
thoroughly reviewed for data extraction. A form 
was generated and used for the data extraction 
during the analysis of the selected iRCT. Data was 
extracted both from full text published iRCT and 
online extra material and registration websites.
Data extraction from the full text of the 
articles
The full text articles were studied and data 
regarding the general characteristics of the 
iRCT, sample size calculation, and statistical 
adjustments made for clustering were recorded. 
General characteristics of the selected 
studies
The journal of publication, the year of publication, 
the type of intervention, number of multicentre 
trials, the health professionals conducting the 
trial, and the presence of clustering were recorded. 
Sample size calculation
The methodology sections of the selected articles 
were studied in full detail, with particular focus 
placed on sample size calculation.  All of the 
parameters used for the calculation of the sample 
size were collected. Any assumptions made 
and justiication for the assumptions were also 
recorded. These parameters included Type I error, 
Type II error or power, one or two tailed tests, type 
of test, assumptions made in the control group, 
and predicted treatment efect.
Adjustment during statistical analysis
The results of the trials were studied and 
analysed for cluster efect adjustments, especially 
during statistical analysis of the results. Various 
models used for the statistical adjustment were 
also recorded.
Data extraction from the online extra 
material and trial registration websites
The trial registration websites were accessed 
and the target sample size and all the parameters 
used for the sample size calculation for the 
retrieved articles were recorded. Additionally, 
the extra materials related to the selected 
articles which were available online were also 
accessed and searched for the target sample 
size calculation and the parameters used for the 
sample size calculation.
RESULTS
Description of the 130 Included 
Articles
Table 1 describes the characteristics of the 
130 selected articles. In 60 trials (46%), the 
intervention was delivered by the doctors, 
including general practitioners, physicians, 
psychiatrists, and surgeons. In the remaining 
included studies, the intervention was delivered 
by nurses in 43 trials (33%), physiotherapists 
in 16 trials (12%), and acupuncturists in the 
remaining 11 trials (9%). In half of the selected 
trials, the intervention was pharmacological, 
with a nonpharmacological intervention used in 
45 (35%) trials. In the remaining 20 trials (15%), 
mixed method interventions were evaluated.
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Types and Prevalence of Clustering
Clustering by centre in multicentre trials was 
found in 79 trials (60%), followed by natural 
clustering, which was found in 26 trials (20%). 
Clustering imposed by the design of the study 
was noticed in 23 trials (18%), while the form of 
clustering was not clear in 2 trials (2%). 
Allowance for Clustering in the 130 
Selected Articles
Table 2 shows the frequency of the trials that 
corrected for the clustering efect in their study 
either by making adjustments while calculating 
the sample sizes or during the statistical 
analysis. Out of the 130 selected articles, 13 were 
published during the year 2000. Among these 
13 trials, only 2 trials (15%) had adjusted for the 
clustering efect. 
Table 1: Baseline characteristics of the articles and details of sample size calculation. 
General characteristics of the 130 included individually randomised controlled trials
Journal Number (%) Health professional Number (%)
BMJ 75(58) Doctors 60(46)
The Lancet 40(31) Nurses 43(33)
Journal of Psychiatry and Neurosciences 15(11) Physiotherapist 16(12)
Acupuncturist 11(9)
Year of publication
2000 13(10) Intervention
2001 10(8) Pharmacological 65(50)
2002 7(5) Nonpharmacological 45(35)
2003 10(8) Both 20(15)
2004 8(6)
2005 11(8) Clustering
2006 21(16) Natural 26(20)
2007 18(14) Imposed 23(18)
2008 19(15) By centre in multicentre 
trials
79(60)
2009 13(10) Not evident 2(2)
Details of sample size calculations for the 130 selected articles
Parameter Number (%)
Articles not reporting a sample size calculation                                      16(12)        
Articles reporting sample size calculations                                               114(88)
1) Reporting all required parameters                                                   61(47)
2) Reporting the power of the study                                                   110(85)
 > 80%                                                                                                     66(60)
 > 85%                                                                                                      7(6)
 > 90%                                                                                                      27(26)
 > 95%                                                                                                      5(4)
 > Other values                                                                                        5(4)
3) Reporting the α risk                                                                             90(82)
 > 0.05                                                                                                    81(90)
 > 0.025                                                                                                   4(4)
 > Interim analysis                                                                                 5(6)
Articles not reporting the target sample size 9(7)
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Likewise, among the 10 trials published during 
2001, only 2 trials (20%) had made allowances 
for the clustering efect. In 2002, 7 articles out 
of the 130 selected articles were published, and 
among these 7, only 2 articles (29%) had taken 
the clustering efect into account. The percentage 
of trials that took various forms of clustering 
into account and had made adjustments in their 
study increased to 45% in 2005 and reached the 
maximum percentage recorded of 67% during 
the year 2007. During the year 2008, 12 trials out 
of 19 (63%) had taken the clustering efect into 
account. In 2009, of all the trials published up 
to the search end date, 31st August 2009, 8 trials 
(62%) showed proper adjustments for various 
forms of the clustering efect.
Ignoring the Clustering Efects in  
the 130 Selected Articles
Table 2 summarises the frequency of articles 
that ignored the clustering efect and made no 
allowance in their design and analysis. Overall, 
69 articles (53%) made no adjustment for the 
clustering efect in their design and analysis. 
Reporting sample size calculations 
Table 1 summarises the data about sample size 
calculation; 16 articles (12%) did not report the 
sample size calculation, while 9 trials (7%) did 
not mention the target sample size, neither in 
the full text report nor on the trial registration 
database. Even though a sample size calculation 
was reported by the majority of articles (88%), 
some of the required parameters for sample size 
calculation were frequently absent in reports. 
In total, 61 articles (47%) included the required 
parameters for sample size calculations, including 
the assumptions made for the treatment efect 
and the control group. Moreover, 110 trials (85%) 
reported the power of the study.  Finally, the α risk 
was mentioned by 90 trials (82%), which mostly 
mentioned the two-tailed test.
DISCUSSION
Principal indings
In this study of 130 iRCT published in three 
medical journals during the 10-year period from 1st 
January 2000–31st August 2009, the potential for 
clustering was found to be very common (98%) 
and only 47% (61/130) of trials studied in this time 
period have made allowances and adjustments 
for the clustering efect in their study design and 
analysis. The time trend analysis showed that the 
trend of taking clustering into account in iRCT has 
Year of study Number of 
articles studied
Total Number of 
iRCT
Number of 
articles with 
clustering
Articles with 
adjustment for 
clustering, n (%)
iRCT not allowing 
for clustering, n 
(%)
2000 39 13 12 2 (15) 11 (85)
2001 32 10 10 2 (20) 8 (80)
2002 20 7 7 2 (29) 5 (71)
2003 28 10 10 3 (33) 7 (67)
2004 24 8 8 3 (38) 5 (62)
2005 32 11 11 5 (45) 6 (55)
2006 63 21 20 12 (57) 9 (43)
2007 56 18 18 12 (67) 6 (33)
2008 48 19 19 12 (63) 7 (37)
2009 39 13 13 8 (62) 5 (38)
Total 381 130 128 61 (47) 69 (53)
Table 2: Frequency of article allowing and/or ignoring for clustering efect.
iRCT: individually randomised controlled trials.
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increased over recent years, from 15% of studies 
implementing anticlustering measures in 2000 
to 67% in 2007, and 63% in 2008. This trend 
still remains high (62%) for the selected trials 
published up to the 31st August 2009 in the three 
selected medical journals.
A plateau in the time trend analysis graph 
during the years 2008 and 2009 warrants further 
investigation into the importance of clustering 
adjustment to further increase the percentage of 
iRCT that adjust for clustering.
Sample size calculations were reported in 88% 
(114/130) of articles. Reporting of the sample 
size calculation has greatly increased in the 
past decades, from 4% of reports describing a 
calculation in 1980 to 83% of reports in 2002.21,22 
However, some of the required parameters for 
replication of the sample size calculation are 
frequently absent in reports. 
STRENGTHS OF THE STUDY
Familiarity with the data
Unlike secondary data analysis, in which the 
data is collected by others and a period of 
familiarisation is necessary, in this study, the 
data has been extracted and collected by the 
researcher, and the data set is self-generated so 
there is marked familiarity with the structure and 
contours of the data.
Presence of key variables
Secondary analysis entails the analysis of data 
collected by others for their own purposes, so 
one or more key variables may not be present.23 
In this study the data has been collected by the 
researcher, so the data about the key variables 
(potential clustering efect, sample size, 
accommodation for clustering) was collected 
with special attention.
Long study span and multiple  
medical journals reviewed
In this study, all the papers published in the 
three medical journals within the 10 years has 
been reviewed. Two of them are general medical 
journals with high impact factors: BMJ and The 
Lancet, while JPN is a specialist medical journal 
with a low impact factor.
Time trend analysis
It was di cult to have a long enough study span 
to analyse the change in trend with time on the 
potential clustering and its accommodation in 
the trials. 
LIMITATIONS OF THE STUDY
It is di cult to assess whether the assumptions 
made in the iRCT during the sample size 
calculation to adjust for the clustering efect had 
been manipulated or not, as only the published 
data about the sample size has been used for 
the study. To obtain feasible sample sizes, the 
assumptions could be manipulated during the 
study.24 Additionally, the sample size calculations 
can be manipulated after the completion of 
the study, as recently shown by Chan et al.25 by 
comparing protocols to inal articles.
The trials with complex designs, such as factorial 
designs, crossover trials, and trials with >2 parallel 
arms, were excluded during the screening process 
to obtain a homogeneous sample of articles. 
Therefore, the clustering efect and its adjustment 
in trials with more complex trials have not been 
assessed. This may limit the generalisability of 
the results.
Another limitation is that the treatment-by-
centre interaction is not considered. However, 
as the main objective of a trial is often to assess 
the overall treatment efect, it is recommended 
to investigate the treatment efect using a model 
that only contains the centre efect.14,26
CONCLUSION
The issue of clustering by health professionals in 
iRCT has gained attention in the last few years, 
and there is need for further research in this ield 
to elicit some more facts about this matter and 
to provide further guidelines about the 
anticipation of, and accommodation for, potential 
clustering. A simulation study will be helpful to 
demonstrate the clustering afect on the results 
of an iRCT. Although each and every form of 
the clustering may not need to be accounted 
for at the analysis stage,27 this paper highlights 
the existence of this issue to the readers and 
reviewers and the need for analysis adjustment in 
certain cases.
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